User:liviaduuy948292
Jump to navigation
Jump to search
The development of targeted therapies for melanoma has seen several promising compounds, most notably Vemurafenib, RO5185426 (Cobimetinib), RG7204 (Selumetinib), and PLX4032 (Plexxicon-4032).
https://omg-directory.com/listings14243622/vemurafenib-ro5185426-rg7204-plx4032-a-comparative-analysis